ArticleCalcified tissue international2026
Disproportionate Decline in Trabecular Bone Score Compared to Bone Mineral Density in Southeast Asian Patients with Thalassemia: A Matched Control Study.
Article in Calcified tissue international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We aimed to assess trabecular bone score (TBS) alongside lumbar spine (LS) and femoral neck (FN) bone mineral density (BMD) in patients with transfusion-dependent thalassemia (TDT) and non-transfusion-dependent thalassemia (NTDT) compared with healthy controls. A cross-sectional study was conducted involving adult thalassemia patients and healthy controls matched at a 2:1 ratio by age and sex. LS and FN BMD and TBS were measured using dual-energy X-ray absorptiometry. Univariate and multivariate analyses were performed to identify factors influencing TBS. The study protocol was approved by the institutional ethics committee. Eighty-six thalassemia patients (mean ± SD age 32.2 ± 11.9 years; 60.5% women) and 172 healthy controls (mean ± SD age 33.7 ± 10.9 years; 60.5% women) were included. Thalassemia patients had significantly lower BMI, LS Z-score, FN Z-score and TBS than controls (all p < 0.001). Only 24.4% of thalassemia patients had normal TBS (≥ 1.350) compared to 77.9% of controls, with a tenfold higher prevalence of degraded microarchitecture (TBS < 1.200). Although TDT patients exhibited more severe disease features than NTDT patients, TBS was similarly reduced in both groups. In multivariate analysis adjusted for age, sex, BMI, and LS BMD, TDT status remained independently associated with lower TBS (β = − 0.047; 95% CI: − 0.083 to − 0.012). No significant correlations were found between TBS and hemoglobin, serum ferritin, lactate dehydrogenase or glucose levels. This study provides new evidence that TBS was significantly impaired in Southeast Asian patients with thalassemia, independent of BMD, with a disproportionate reduction observed particularly in TDT patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.